What is Jello Labs?
Jello Labs operates as a specialized AI healthcare entity, focusing on the sophisticated analysis of personal health data derived from Electronic Health Record (EHR) systems. The organization provides a suite of high-impact services, including AI-driven consultation, seamless EHR integration, and comprehensive data insight sessions. By bridging the gap between raw clinical data and actionable intelligence, Jello Labs enables healthcare providers to optimize operational efficiency while simultaneously elevating the standard of patient care. Their market position is defined by a commitment to data-driven decision-making, serving as a vital partner for healthcare institutions navigating the complexities of digital transformation.
How much funding has Jello Labs raised?
Jello Labs has raised a total of $7.5M across 1 funding round:
Series A
$7.5M
Series A (2014): $7.5M with participation from Thrive Capital
Key Investors in Jello Labs
Thrive Capital
Thrive Capital is a prominent venture capital firm based in New York that focuses on high-growth internet and software companies.
What's next for Jello Labs?
With this major strategic investment, Jello Labs is poised to scale its infrastructure and expand its footprint within the competitive health-tech sector. The capital will likely be deployed to enhance the robustness of its AI algorithms and broaden its integration capabilities across diverse EHR platforms. As the healthcare industry increasingly prioritizes predictive analytics and personalized medicine, Jello Labs is strategically aligned to capture significant market share. Future initiatives will likely focus on deepening institutional partnerships and refining its proprietary technology to meet the growing demand for automated, high-precision clinical insights.
See full Jello Labs company page
